145 related articles for article (PubMed ID: 10907474)
1. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
Lo Coco F; Diverio D; Avvisati G; Mandelli F
Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
[No Abstract] [Full Text] [Related]
2. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization.
Gutiérrez NC; García JL; Chillón C; Muntión S; González M; Hernández JM
Haematologica; 1999 Jan; 84(1):88-90. PubMed ID: 10091399
[No Abstract] [Full Text] [Related]
3. Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
Cassinat B; Guillemot I; Moluçon-Chabrot C; Zassadowski F; Fenaux P; Tournilhac O; Chomienne C
Haematologica; 2006 Dec; 91(12 Suppl):ECR58. PubMed ID: 17194664
[TBL] [Abstract][Full Text] [Related]
4. Two new molecular PML-RARalpha variants: implications for the molecular diagnosis of APL.
Vizmanos JL; Larrráyoz MJ; Odero MD; Lasa R; González M; Novo FJ; Calasanz MJ
Haematologica; 2002 Aug; 87(8):ELT37. PubMed ID: 12161382
[No Abstract] [Full Text] [Related]
5. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
Dalal BI; Bruyere H; Barnett MJ
Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
[No Abstract] [Full Text] [Related]
6. Patchy polyneuropathy in acute promyelocytic leukaemia.
Win N; Mitchell DC
Clin Lab Haematol; 1992; 14(1):87-90. PubMed ID: 1318179
[No Abstract] [Full Text] [Related]
7. Long-term molecular remission in promyelocytic transformation of myeloproliferative disease.
Mollee PN; Taylor KM; Williams B; Taylor D; Rodwell R
Leukemia; 1999 Apr; 13(4):648-50. PubMed ID: 10214878
[No Abstract] [Full Text] [Related]
8. The APL-associated fusion proteins.
Minucci S; Cioce M; Maccarana M; Pelicci PG
Haematologica; 1999 Jun; 84 Suppl EHA-4():70-1. PubMed ID: 10907473
[No Abstract] [Full Text] [Related]
9. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
Breccia M; Diverio D; Noguera NI; Visani G; Santoro A; Locatelli F; Damiani D; Marmont F; Vignetti M; Petti MC; Lo Coco F
Haematologica; 2004 Jan; 89(1):29-33. PubMed ID: 14754603
[TBL] [Abstract][Full Text] [Related]
10. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
Randolph TR
Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia with del(6)(p23).
Nakase K; Wakita Y; Minamikawa K; Yamaguchi T; Shiku H
Leuk Res; 2000 Jan; 24(1):79-81. PubMed ID: 10634650
[TBL] [Abstract][Full Text] [Related]
12. Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level.
Martinelli G; Ottaviani E; Visani G; Testoni N; Montefusco V; Tura S
Haematologica; 1998 Sep; 83(9):860-3. PubMed ID: 9825588
[TBL] [Abstract][Full Text] [Related]
13. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML).
George B; Poonkuzhali B; Srivastava VM; Chandy M; Srivastava A
Ann Hematol; 2005 Jun; 84(6):406-8. PubMed ID: 15592671
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
Dunkley S; Gibson J; Iland H; Li C; Joshua D
Leuk Lymphoma; 1999 Nov; 35(5-6):623-6. PubMed ID: 10609802
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
Bao L; Lu X; Lai Y; Zhang X; Zhu H; Liu Y; Qin Y; Huang XJ
Leuk Res; 2009 Jul; 33(7):e64-8. PubMed ID: 19297021
[No Abstract] [Full Text] [Related]
16. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
García-Casado Z; Cervera J; Valencia A; Pajuelo JC; Mena-Duran AV; Barragán E; Bolufer P; Sanz MA
Cancer Genet Cytogenet; 2006 Jul; 168(1):73-6. PubMed ID: 16772124
[TBL] [Abstract][Full Text] [Related]
17. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
18. [Detection of t(15;17) using cytogenetic, fluorescent in situ hybridization, and molecular techniques. Comparative study of 11 patients with acute promyelocytic leukemia].
Arranz E; Robledo M; Martínez B; Prieto E; Román A; Benítez J
Sangre (Barc); 1997 Feb; 42(1):11-5. PubMed ID: 9229797
[TBL] [Abstract][Full Text] [Related]
19. Complex translocations derived stepwise from standard t(15;17) in a patient with variant acute promyelocytic leukemia.
Miyazaki K; Kikukawa M; Kiuchi A; Shin K; Iwamoto T; Ohyashiki K
Cancer Genet Cytogenet; 2007 Jul; 176(2):127-30. PubMed ID: 17656255
[TBL] [Abstract][Full Text] [Related]
20. Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17).
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Willman CL
Leukemia; 2000 Jul; 14(7):1197-200. PubMed ID: 10914542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
